Evidence mapPaperPMID 37809159Full record

ReviewCureus2023

DASH Diet: A Review of Its Scientifically Proven Hypertension Reduction and Health Benefits.

Chidera Onwuzo, John O Olukorode, Olutomiwa A Omokore, Oluwatobi S Odunaike, Raymond Omiko, Osadebamwen W Osaghae, Walid Sange, Dolapo A Orimoloye, Heritage O Kristilere, Ehizobhen Addeh and 2 more

Abstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Dietary patterns to promote cardiometabolic health.Nature reviews. Cardiology · 2025
    Review
  16. Strategies to Manage Obesity: Lifestyle.Methodist DeBakey cardiovascular journal · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chidera OnwuzoInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
John O OlukorodeInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
Olutomiwa A OmokoreInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
Oluwatobi S OdunaikeInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
Raymond OmikoInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
Osadebamwen W OsaghaeInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
Walid SangeInternal Medicine, K. J. Somaiya Medical College and Research Centre, Mumbai, IND.
Dolapo A OrimoloyeInternal Medicine, College of Medicine University of Lagos, Lagos, NGA.
Heritage O KristilereInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
Ehizobhen AddehInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.
Somtochukwu OnwuzoInternal Medicine, Cleveland Clinic Foundation, Cleveland, USA.
Lisa OmoragbonInternal Medicine, Benjamin S. Carson (Snr) College of Health and Medical Sciences, Ilishan-Remo, NGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Dietary Approach to Stop Hypertension (DASH) constitutes a nonpharmacological dietary strategy tailored with the primary objective of mitigating hypertension and averting its potential complications. Numerous clinical studies, such as the PREMIER trial, DASH sodium study, and OmniHeart trial, as well as other studies, substantiate the DASH diet's ability to manage hypertension. Beyond its profound impact on hypertension reduction, the DASH diet has exhibited notable efficacy in addressing an array of conditions such as heart failure, lipid homeostasis, dyslipidemia, and uric acid dysregulation. With its empirical foundation, the DASH diet emerges as an indispensable tool in the hypertension management toolkit, warranting its exploration and integration into various medical contexts. This review commences with an overview of both the DASH diet and the significance of hypertension as a prevailing health concern. The ensuing discussion meticulously examines the extensive body of clinical research, firmly establishing the DASH diet's prowess in hypertension management. Furthermore, this review delves into the strategic approaches necessary for the successful implementation of the DASH diet, outlining the roles of technology and governmental responsibilities in ensuring its widespread adoption. As a comprehensive examination of the DASH diet's efficacy and potential, this review underscores its significance in modern healthcare paradigms.

Indexed as

approach to dash dietbenefit of dash dietclinical trialsdash diethypertension

Identifiers

PMID37809159
PMCPMC10551663

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.